Inotiv, Inc. to Attend September Investor Conferences | National

WEST LAFAYETTE, Ind., Aug. 31, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a contract research organization of leading provider of non-clinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor , Chief Financial Officer, are expected to attend the following investor conferences in September:

  • Wells Fargo Healthcare Conference 2022
    Boston, Massachusetts / September 7-9
    Individual meetings
  • Lake Street Capital Markets 6th Annual Great Ideas Growth Conference
    New York / September 14, 2022
    Individual meetings

About the company

Inotiv, Inc. is a leading contract research organization dedicated to providing non-clinical and analytical services in drug discovery and development, research models and related products and services. The Company’s products and services aim to bring new drugs and medical devices through the discovery and preclinical development phases, while increasing efficiency, improving data and reducing the cost of bringing new products to market. medications. Inotiv is committed to supporting discovery and development goals as well as helping researchers realize the full potential of their critical R&D projects, while working together to build a healthier and safer world. You can find more information about Inotiv here:

This release may contain forward-looking statements that are subject to risks and uncertainties, including, but not limited to, risks and uncertainties relating to changes in the market and demand for our products and services, the development, marketing and sale of products and services, changes in technology, industry and regulatory standards, timing of acquisitions and successful closing, integration and the business and financial impact thereof, government regulations, inspections and investigations, the impact of site closures and consolidations, expansion and related efforts, and various other market and operational risks, including those detailed in the Company’s filings with the Securities and Exchange United States Commission.

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.